RENAL SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR WITH HEPATITIS B IMMUNOGLOBULIN IN LIVER TRANSPLANT PATIENTS

被引：0
|
作者：
Lee, Juhan [1 ]
Park, Jun Yong [2 ]
Yang, Seok Jeong [1 ]
Lee, Jee Youn [3 ]
Kim, Deok Gie [4 ]
Joo, Dong Jin [1 ]
Kim, Myoung Soo [1 ]
Kim, Soon Il [1 ]
Lee, Jae Geun [1 ]
机构：
[1] Yonsei Univ, Surg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Internal Med, Coll Med, Seoul, South Korea
[3] Gangbuk Samsung Med Ctr, Surg, Seoul, South Korea
[4] Wonju Severance Christian Hosp, Surg, Wonju, South Korea
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-12.106
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [21] Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
    Woldemedihn, Gezahegn M.
    Aberra, Hanna
    Desalegn, Hailemichael
    Berhe, Nega
    Belay, Denekew Bitew
    Rueegg, Corina S.
    Johannessen, Asgeir
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [22] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients
    Butt, N.
    Rai, L.
    Hussain, R.
    Khemani, H.
    Ali, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 84 - 84
  • [23] Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation
    Vasudevan, Abhinav
    Ardalan, Zaid S.
    Ahmed, Navera
    Apostolov, Ross
    Gow, Paul J.
    Testro, Adam G.
    Gane, Ed J.
    Angus, Peter W.
    JGH OPEN, 2018, 2 (06): : 288 - 294
  • [24] Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue
    Lee, Sung Won
    Kim, Seung Up
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 889 - 890
  • [25] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B
    Zhang, Xueyun
    Hu, Qiankun
    Liu, Xiaoqin
    Huang, Yuxian
    HEPATOLOGY, 2021, 74 : 490A - 491A
  • [26] AN EFFICACY OF CONTINUING TENOFOVIR DISOPROXIL FUMARATE VERSUS SWITCHING ENTECAVIR TO TENOFOVIR DISOPROXIL FUMARATE IN TREATMENT OF CHRONIC HEPATITIS B PATIENTS: 5-YEAR FOLLOW UP
    Ungtrakul, Teerapat
    Chiersilpa, Kunsuda
    Yingcharoen, Kesinee
    Jiraphairot, Suppawat
    Sangwipasnapaporn, Worrawat
    Dechma, Jiraporn
    Chunnuan, Pitchayachuda
    Kusuman, Pattama
    Pothijaroen, Charinthip
    Tawpa, Jantarika
    Hankla, Pimprapa
    Numahan, Apichayaporn
    Pongpun, Wanwisa
    Soonklang, Kamonwan
    GUT, 2022, 71 : A72 - A72
  • [27] Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Jeong, Sara
    Shin, Hyun Phil
    Kim, Ha Il
    INTERVIROLOGY, 2022, 65 (02) : 94 - 103
  • [28] Tenofovir Disoproxil Fumarate Alone or in Combination With Entecavir in Patients With Entecavir-Resistant Chronic Hepatitis B: Multicenter Randomized Trial
    Lim, Young-Suk
    Byun, Kwan Soo
    Gwak, Geum-Youn
    Yoo, Byung Chul
    Kwon, So Young
    Kim, Yoon Jun
    An, Jihyun
    Lee, Han Chu
    Lee, Yung Sang
    HEPATOLOGY, 2014, 60 : 315A - 315A
  • [29] Effect of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamideantiviral Therapy on Renal Function in Chronic Hepatitis B Patients: A Real-World Retrospective Study
    Li, Yu
    Li, Ya-Wei
    Gao, Ying
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2025, 18 : 1143 - 1153
  • [30] Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
    Cheng, Chih-Hsien
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    ANNALS OF TRANSPLANTATION, 2023, 28
12345